VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2023. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,987,000 | -5.8% | 850,000 | -8.2% | 2.38% | +14.5% |
| Q2 2023 | $7,415,497 | -1.1% | 925,780 | 0.0% | 2.08% | +1.8% |
| Q1 2023 | $7,498,818 | +28.3% | 925,780 | -0.6% | 2.04% | +35.6% |
| Q4 2022 | $5,846,680 | -8.8% | 931,000 | 0.0% | 1.51% | -14.5% |
| Q3 2022 | $6,414,000 | -44.4% | 931,000 | -32.6% | 1.76% | -35.0% |
| Q2 2022 | $11,531,000 | -63.5% | 1,381,000 | 0.0% | 2.71% | -58.0% |
| Q1 2022 | $31,555,000 | -17.2% | 1,381,000 | 0.0% | 6.45% | -15.4% |
| Q4 2021 | $38,129,000 | -0.9% | 1,381,000 | 0.0% | 7.62% | -6.7% |
| Q3 2021 | $38,460,000 | -8.0% | 1,381,000 | -3.2% | 8.17% | +2.3% |
| Q2 2021 | $41,810,000 | -7.7% | 1,426,000 | -0.1% | 7.98% | -5.9% |
| Q1 2021 | $45,292,000 | +52.6% | 1,427,000 | 0.0% | 8.48% | +48.3% |
| Q4 2020 | $29,681,000 | +33.8% | 1,427,000 | 0.0% | 5.72% | +24.6% |
| Q3 2020 | $22,175,000 | -11.0% | 1,427,000 | +4.8% | 4.59% | -15.2% |
| Q2 2020 | $24,910,000 | +22.5% | 1,362,000 | +3.8% | 5.41% | +15.6% |
| Q1 2020 | $20,336,000 | -40.4% | 1,312,000 | +15.0% | 4.68% | -29.7% |
| Q4 2019 | $34,138,000 | +57.7% | 1,141,000 | +15.1% | 6.66% | +48.1% |
| Q3 2019 | $21,653,000 | -4.2% | 991,000 | +10.6% | 4.50% | -6.7% |
| Q2 2019 | $22,597,000 | -5.8% | 896,000 | -7.7% | 4.82% | +2.8% |
| Q1 2019 | $23,983,000 | +35.3% | 971,000 | +1.1% | 4.68% | +24.1% |
| Q4 2018 | $17,731,000 | -24.0% | 960,000 | +5.5% | 3.78% | -16.5% |
| Q3 2018 | $23,341,000 | +16.8% | 910,000 | +5.8% | 4.52% | +13.7% |
| Q2 2018 | $19,986,000 | +46.8% | 860,000 | +0.6% | 3.98% | +40.0% |
| Q1 2018 | $13,611,000 | +9.4% | 855,000 | +42.7% | 2.84% | +5.4% |
| Q4 2017 | $12,447,000 | +49.5% | 599,000 | +3.1% | 2.70% | +44.9% |
| Q3 2017 | $8,325,000 | -17.2% | 581,000 | 0.0% | 1.86% | -18.9% |
| Q2 2017 | $10,051,000 | – | 581,000 | – | 2.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |